July 7, 2020 / 1:32 PM / a month ago

BRIEF-Cerus Corp Reports Successful Inactivation Of Sars-Cov-2 With The Intercept Blood System For Plasma

July 7 (Reuters) - Cerus Corp:

* CERUS CORPORATION REPORTS SUCCESSFUL INACTIVATION OF SARS-COV-2 WITH THE INTERCEPT BLOOD SYSTEM FOR PLASMA

* CERUS - DATA CONSISTENT WITH PRIOR INTERCEPT STUDIES SHOWING COMPLETE INACTIVATION, TO BELOW LIMIT OF DETECTION, OF OTHER CORONAVIRUSES

* CERUS - INACTIVATION DATA SHOWS INTERCEPT BLOOD SYSTEM MAY LOWER POTENTIAL RISK OF SARS-COV-2 TRANSMISSION BY CONVALESCENT PLASMA TRANSFUSION FROM RECOVERED PATIENTS

* CERUS - CONDUCTING IN VITRO STUDIES IN U.S. TO ASSESS INTERCEPT BLOOD SYSTEM’S ABILITY TO INACTIVATE SARS-COV-2 IN RED BLOOD CELLS, PLATELETS & PLASMA Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below